medigraphic.com
ISSN 1995-9427 (Print)

2021, Number 1

<< Back Next >>

Invest Medicoquir 2021; 13 (1)

Anti-Tuberculosis Chemotherapy in patients with history of living in a closed setting, Central Region of Cuba

Calzado BA, González DA, González OE, Armas PL, León VMÁ, Oliva NN

Language: Spanish
References: 49
Page:
PDF size: 332.39 Kb.


ABSTRACT

Introduction. The Cuban goal Tuberculosis (TB) control is the 98 % of cured and 95 % proportion of successfully completed treatment. Methods. This retrospective cohort study with central region cases TB notified, had the aim to determinate the effectivity of anti-tuberculosis drugs in patients with history of living in a closed setting during 2009-2010. To the quantitative variables were estimated standard variation with intercuartiles ranges and to the qualitative variables absolutes frequencies and percentage. To the effectivity of treatment was determinate the proportion of smear-positive pulmonary TB cases that were negative ending the treatment. In the case of smear-positive pulmonary TB and extrapulmonary TB cases it takes which complete the treatment. Results. Of 103 analyzed outcomes cases, 90(87, 4 %) was cured and 13(12,6 %)failure. Of failure rate predominate defaulter (46,1 %). Mostly were male (99,0 %) between those aged 25-64 years and habited in Villa Clara (37,8 %) and Ciego de Ávila (31,1 %) province. The majority were smear-positive pulmonary TB (75,7 %) and 31,1 % was alcoholism addiction. Success treatment rate was 91 %, in new case was 90% and in retreatment cases was 69%. Conclusions. that central region cases tuberculosis with history of living in a closed setting notified were male, the majority of them belonged to economically productive age group, The dates of the effectivity of anti-Tuberculosis drugs were low from National Tuberculosis Control Program goal.


REFERENCES

  1. World Health Organization. The global Plan to Stop TB 2011–2015. Geneva: WHO; 2010.

  2. Fernández Méndez L. Tuberculosis Pulmonar con Baciloscopía positiva en municipios seleccionados de Ciudad de la Habana y Las Tunas: noviembre 2003-octubre 2005[Tesis para optar por título de máster en Epidemiología]. La Habana: IPK; 2009.

  3. World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO Report 2005. Geneva: WHO; 2005.

  4. González OE, De Armas L. Tuberculosis, procedimientos para su vigilancia y control: experiencia cubana, La Habana; 2010.

  5. Organización Panamericana de la Salud. Guía para el control de la tuberculosis en poblaciones privadas de libertad de América Latina y el Caribe. Washington, D.C.: OPS, 2008.

  6. De Armas Pérez L. La quimioterapia Antituberculosa en Cuba: 1963-2007[Tesis para optar por título de máster en Epidemiología]. La Habana: IPK; 2008.

  7. C Dye, Lönnroth K, Jaramillo E. Trends in tuberculosis incidence and their determinants in134 countries. Bull World Health Organ. 2009; 87:683–91.

  8. Kassam N, Fanning A. Outcome of tuberculosis treatment: A comparison between Alberta and Nicaragua. Can J Infect Dis. 2006; 11(2): 93–6.

  9. De Armas L, González OE, González A. Importancia de la evaluación de la quimioterapia en pacientes con tuberculosis. MEDISAN. 2011; 15(8):11-8.

  10. OPS. Tuberculosis in the Américas: Regional Report 2008 [on line] .2009 [citado el 30 de octubre de 2009]. Disponible en: http://new.paho.org/hq.

  11. Ministerio de Salud Pública. Anuario Nacional de Estadísticas 2010.La Habana: MINSAP; 2010.

  12. ONE. Anuarios de Estadístico de Camagüey, Cienfuegos, Ciego de Ávila, Villa Clara y Sancti-Espíritus [Internet]. La Habana; 2010. [citado el 8 de enero de 2012]. Disponible en: http://www.one.cu.

  13. Ministerio de Salud Pública. Manual de Normas y Procedimientos del control de la Tuberculosis. 2 da ed. La Habana: MINSAP; 2009.

  14. World Health Organization. Global Tuberculosis Control: WHO Report 2011. Geneva: WHO; 2011.

  15. Legrand J, Sánchez A, Le Pont F, Camacho L, Larouze B. Modeling the Impact of Tuberculosis Control Strategies in Highly Endemic Overcrowded Prisons. PLoS ONE.2008; 3(5): 1371-3.

  16. Organización Panamericana de la Salud. Guía para el control de la tuberculosis en poblaciones privadas de libertad de América Latina y el Caribe. Washington, D.C.: OPS, 2008.

  17. Diuana V. Health in the prison system: representations and practices by prison guards in Rio de Janeiro, Brazil. Cad. Saúde Pública. 2008; 24(8):1887-96.

  18. Mor Z. Tuberculosis Behind Bars in Israel: Policy Making Within a Dynamic Situation. IMAJ. 2008; 10: 202–6.

  19. Duarte B, López S, Gallardo G, Cabrera O, Pérez JM. Evaluación del Programa de Tuberculosis en Instituciones Cerradas. Rev. Ciencias Médicas 2015; 19(2):253-265.

  20. Diaz R, Kremer K, de Haas PE, Gomez RI, Marrero A, et al. Molecular epidemiology of tuberculosis in Cuba outside of Havana, July 1994-June 1995: utility of spoligotyping versus IS6110 restriction fragment length polymorphism. Int J Tuberc Lung Dis 1998; 2: 743-50.

  21. González A, Battaglioli T, Diaz R, Goza R, González Edilberto, Van Der Stuyft P. Molecular Epidemiology of Tuberculosis in Havana, Cuba, 2009.Trop Med Int Health 2015;20 (11):1534-1542.

  22. OMS. Global Tuberculosis Control. Surveillance, Planning, Financing. WHO Report [Internet]. Geneva; 2008. [citado 6 de noviembre de 2010]. Disponible en: http://www.who.int/ tb/publications/globalreport/2008/downloadcentre/en/index.html.

  23. Maamari F. Case-finding tuberculosis patients: diagnostic and treatment delays and their determinants. Eastern Mediterranean Health Journal. 2008; 14(3):531-45.

  24. Dirección Nacional de Registros Médicos y Estadísticas de Salud. Series de Tiempo de Morbilidad 1970-2007.La Habana: DNRMES; 2008.

  25. Gaceta Oficial de la República de Cuba. Ley No. 105 de Seguridad Social. [Internet]. La Habana; 2009. [citado el 11 de enero de 2012]. Disponible en: http://www.gacetaoficial.cu/.

  26. Pérez Soler K. Estratificación, tendencias y proyecciones de la tuberculosis por regiones. Cuba, 199-2013[Tesis para optar por título de máster en Epidemiología]. La Habana: IPK; 2010.

  27. Ministerio de Salud Pública. Anuario Nacional de Estadísticas 2008.La Habana: MINSAP; 2008.

  28. ONE. Población de Cuba por provincias. 2008[Internet]. La Habana; 2009. [citado el 8 de enero de 2012]. Disponible en: http://www.one.cu.

  29. Ministerio de Salud Pública. Anuario Nacional de Estadísticas 2006.La Habana: MINSAP; 2006.

  30. Ministerio de Salud Pública. Anuario Nacional de Estadísticas 2007.La Habana: MINSAP; 2007.

  31. Ministerio de Salud Pública. Anuario Nacional de Estadísticas 2009.La Habana: MINSAP; 2009.

  32. Jordan TS, Davies PD. Clinical tuberculosis and treatment outcomes. INT J Tuberc Lung Dis. 2010; 14(6):683–8.

  33. Pan American Health Organization / World Health Organization. Epidemiological and operational situation of tuberculosis (TB) in prisons of the Latin American Region, Pan American Health Organization, TB Regional Program. Washington, D.C. PAHO/WHO; 2004.

  34. Llanes MJ. Tuberculosis pulmonar con baciloscopía negativa, peculiaridades de su frecuencia en Cuba 1992-2002. Rev cubana Med Trop. 2006; 58(2):119-23.

  35. World Health Organization. Global Tuberculosis Control: surveillance, planning, financing: WHO Report 2010. Geneva: WHO; 2010.

  36. Reyes A, Díaz M, Pérez A, Bouza Y. Factores asociados con la presencia de tuberculosis en pacientes con el síndrome de inmunodeficiencia adquirida en Cuba. Rev Panam Salud Pública. 2004; 15(5):341–7.

  37. Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C, Unwin N: Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health. 2007; 7:234.

  38. Harries AD, Murray MB, Jeon CY. Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis. Trop Med Int Health. 2010; 15: 659-63.

  39. Lönnroth K, Castro K, Chakaya JM. Tuberculosis control and elimination 2010—50: cure, care, and social development. Lancet .2010; 375: 1814-29.

  40. Ottmani SE, Murray MB, Jeon CY. Consultation meeting on tuberculosis and diabetes mellitus: meeting summary and recommendations. Int J Tuberc Lung Dis 2010; 14: 1513-17.

  41. Jeon C Y, Murray M B. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008; 5: e152.

  42. Organización Panamericana de la Salud. Salud en las Américas. Washington, D.C.: OPS; 2007.

  43. Chiang C-Y, Lee J-J. Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death. Int J Tuberc Lung Dis. 2009; 13(1):105–11.

  44. Fleming MF, Krupitsky E, Tsoy M, Zvartau E, Brazhenko N, Jakubowiak W, McCaul ME: Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients. Int J Tuberc Lung Dis .2006; 10:565-70.

  45. Laifer G, Widmer AF, Bassetti S, Trampuz A, Frei R, Tamm M. TB in a low-incidence country: differences between new immigrants, foreign-born residents and native residents. Am J Med. 2007; 120:350-6.

  46. Lönnroth K, Williams BG, Stadlin S. Alcohol use as a risk factor for tuberculosis – a systematic review. BMC Public Health .2008; 8:289-92.

  47. Kolappan C, Gopi PG, Subramani R, Narayanan PR. Selected biological and behavioural risk factors associated with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2007; 11:999-1003.

  48. Gaviria MB, Henao HN. Papel del personal de salud en el diagnóstico tardío de la tuberculosis pulmonar en adultos de Medellín, Colombia. Rev Panam Salud Pública.2010; 27(2):83-92.

  49. Cáceres FM, Orozco LC. Demora en el diagnóstico de tuberculosis pulmonar en una región de Colombia. Rev Salud Pública. 2008; 10(1):94–104.




2020     |     www.medigraphic.com